Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Metabolic Syndrome on Development of Contrast Induced Nephropathy After Elective Percutaneous Coronary Intervention

NCT02192372 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT02192372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02192372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Metabolic Syndrome on Development of Contrast Induced Nephropathy After Elective Percutaneous Coronary Intervention
Lead sponsor
Ankara University
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
July 31, 2014
Enrollment
599 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy, metabolic syndrome